Docoh
Loading...

LLY Lilly(Eli) & Co

Lilly is a global health care leader that unites caring with discovery to create medicines that make life better for people around the world. It was founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today it remains true to that mission in all its work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

Company profile

Ticker
LLY
Exchange
Website
CEO
David Ricks
Employees
Incorporated
Location
Fiscal year end
Former names
LILLY ELI & CO, LILLY ELI & CO ET AL
SEC CIK
IRS number
350470950

LLY stock data

(
)

Press releases

Pro users get this 30m faster

Calendar

17 Feb 21
18 Apr 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
15 Mar 21 Kimberly H Johnson Common Stock Grant Aquire A No No 189.16 51 9.65K 51
15 Mar 21 Tai Jackson P Common Stock Grant Aquire A No No 189.16 10 1.89K 59,819
15 Mar 21 Alvarez Ralph Common Stock Grant Aquire A No No 189.16 58 10.97K 49,459
9 Mar 21 Lilly Endowment Common Stock Sell Dispose S No No 211.901 1,726 365.74K 110,302,100
9 Mar 21 Lilly Endowment Common Stock Sell Dispose S No No 211.133 7,720 1.63M 110,303,826
9 Mar 21 Lilly Endowment Common Stock Sell Dispose S No No 210.278 17,270 3.63M 110,311,546
9 Mar 21 Lilly Endowment Common Stock Sell Dispose S No No 209.122 33,243 6.95M 110,328,816
8 Mar 21 Lilly Endowment Common Stock Sell Dispose S No No 210.118 60,874 12.79M 110,362,059
8 Mar 21 Lilly Endowment Common Stock Sell Dispose S No No 209.29 64,410 13.48M 110,422,933

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

81.9% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 1836 1735 +5.8%
Opened positions 236 139 +69.8%
Closed positions 135 129 +4.7%
Increased positions 638 609 +4.8%
Reduced positions 659 656 +0.5%
13F shares
Current Prev Q Change
Total value 132.6B 107.44B +23.4%
Total shares 785.47M 725.13M +8.3%
Total puts 4.46M 3.73M +19.6%
Total calls 4.41M 2.58M +70.8%
Total put/call ratio 1.0 1.4 -30.0%
Largest owners
Shares Value Change
Lilly Endowment 111.13M $18.76B 0.0%
Vanguard 68.66M $11.59B -0.7%
BLK Blackrock 58.81M $9.93B -2.7%
PNC PNC Financial Services 52.33M $8.84B +2122.0%
Primecap Management 36.76M $6.21B -3.2%
STT State Street 33.47M $5.65B -4.2%
Wellington Management 33.15M $5.6B +30.9%
FMR 25.63M $4.33B -14.2%
JPM JPMorgan Chase & Co. 21.52M $3.63B +14.2%
State Farm Mutual Automobile Insurance 18.62M $3.14B 0.0%
Largest transactions
Shares Bought/sold Change
PNC PNC Financial Services 52.33M +49.98M +2122.0%
Norges Bank 8.67M +8.67M NEW
Wellington Management 33.15M +7.83M +30.9%
Capital International Investors 11.37M -4.77M -29.6%
FMR 25.63M -4.23M -14.2%
TROW T. Rowe Price 12.09M +4.08M +51.0%
Jennison Associates 1.88M -2.7M -59.0%
JPM JPMorgan Chase & Co. 21.52M +2.67M +14.2%
IVZ Invesco 6.46M +1.91M +41.9%
Two Sigma Advisers 193.42K -1.89M -90.7%
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: AbCellera, advisory, Agener, ALK, Alkem, Almirall, anchored, antagonist, API, Asahi, Ascend, ascending, Ashkenazi, Asian, Attached, attract, attracting, aura, axial, axonal, baicker, bamlanivimab, BePurchased, bertozzi, BI, billing, bioavailable, bisexual, bispecific, Bowfin, BPCIA, build, burdened, Campaign, career, carolyn, ceiling, child, childcare, Citibank, classic, cloud, cohesive, Columbia, compel, compensatory, Congressional, Conjugate, Connecticut, Consent, context, core, coupled, creation, cultivate, custody, CVR, declared, deeply, Deferral, degeneration, deputy, Deutsche, diagnosed, diagnosing, Disarm, dispensing, dispute, distancing, DiversityInc, donald, Donanemab, donation, double, duly, editing, ejection, emphasized, enjoining, ERG, ergonomic, erik, eskew, etesevimab, Ethisphere, EUA, Evox, exacerbate, excellence, explained, export, feedback, feel, Fochon, fostering, foundation, Fournier, fraction, Francisco, French, fyrwald, gangrene, garnered, gay, genetic, goal, grew, hacking, halt, halted, Hampshire, Heart, heightened, hematological, Hematology, HHS, hiring, Hodgkin, home, Hong, honoring, Hopira, hosting, household, HR, HRSA, Hub, Ilya, inapplicable, indirectly, ineffective, Inline, instance, intensify, jackson, Job, jr, juan, Junshi, justifying, kaelin, katherine, kathi, kidney, KIMBERLY, Kong, Latinx, leader, leadership, learning, left, lesbian, LGBTQ, licensure, lifesaving, LillyNow, luciano, lymphoma, Lyumjev, mAb, Macau, Magazine, mainland, markup, marschall, meaningful, Medco, medullary, Membership, MGM, Minister, modality, modest, moral, Mother, Multicultural, Mylan, neurological, Newsweek, NILEX, Nonalcoholic, nondiscrimination, ofPublicly, older, omitted, online, ordinary, overarching, overturned, overturning, Page, Paidper, patching, paused, payroll, Perfect, Petitioner, pharmacology, pool, postponed, potency, presence, presidential, principle, prioritization, protamine, protracted, psychological, purity, queer, question, questioning, recession, recouping, refractory, refund, reimportation, relapsed, remdesivir, remediate, remote, repaid, representation, resource, Retevmo, Retsevmo, revoked, robust, Rochester, runge, RVA, Score, scrutiny, secondary, seifert, SELIC, Semglee, Shanghai, SharesPurchased, shortage, sintilimab, Sitryx, Society, sooner, speed, spread, Stamford, steal, storage, straight, strain, strictly, subset, sued, Suppurativa, switching, tai, Taiwan, talent, talented, TauvidTM, thereunto, thought, threatened, Thrive, top, Toronto, transgender, transient, transmission, travel, treatement, Tripartite, trustee, twelve, Tyvyt, unapproved, underrepresented, undersigned, unemployment, unexpectedly, unfunded, unlawful, unrelated, unsuccessfully, Valueof, video, violate, violated, viral, virtual, vivo, voting, warning, widespread, william, woman, workplace, XBRL, Yuffa, Zagotenemab, zakrowski, Zentiva
Removed: Abasaglar, accelerating, Accountant, Adcirca, Axiron, bacteria, Baxter, beta, body, BPCI, brain, calcitonin, called, cancelable, CGRP, chair, character, CoLucid, compute, concomitantly, CureVac, deficiency, displacement, distinguished, DOJ, earliest, earning, Effient, emission, endocrinology, erode, eroded, exercised, expend, expiring, front, fundamentally, galcanezumab, geography, glucagon, healthy, hormone, Humatrope, Hurricane, hyperactivity, IIb, illustrated, image, imaging, Immunological, injected, injury, inside, installment, insufficient, insurer, irrelevant, Joshua, KeyBioscience, lanabecestat, Maria, McKesson, Medtronic, metabolic, Mine, Missouri, Mutual, Nektar, neurofibrillary, Nipro, NME, Nomination, noncancelable, nonqualified, Notwithstanding, novelty, obsolescence, offered, Ohio, opt, peptide, pet, positron, predetermined, prejudice, protein, provisional, purporting, pursued, Ratify, Reddy, refining, remeasurement, remeasuring, rewarded, sarcoma, Sawai, screening, shut, side, significance, Smiley, soft, statistical, Strafford, stranded, Strattera, structural, study, studying, subcutaneously, suspended, targeted, taxation, testosterone, tissue, tomography, topic, toxicity, tracer, Unresolved, voluntarily